Recent US drug recalls
Every drug recall the FDA has reported, most serious first.
Every drug recall the FDA has reported, most serious first.
The FDA publishes recalls weekly, so this runs to its latest update, not today. Class I is the most serious.
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Microbial Contamination of Sterile Products
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Assurance of Sterility
Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.
Lack of Processing Controls
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications.
Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Failed Impurities/Degradation Specifications
Lack of Processing Controls
Presence of Foreign Tablets/Capsules
Lack of Processing Controls
Lack of Processing Controls
Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Lack of Processing Controls
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
CGMP Deviations
CGMP Deviations
Failed Dissolution Specifications.
CGMP Deviations
Failed Impurities/Degradation Specification; detection of polyethylene (PE)-related oligomers
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
Manufacturer is recalling batches due to co-mingled tablet.
CGMP Deviations
Failed Impurities/Degradation Specification
CGMP Deviations
Subpotent Drug
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
Lack of Assurance of Sterility
CGMP Deviations
Presence of Foreign Tablets/Capsules
Lack of Assurance of Sterility
Labeling: Not Elsewhere Classified
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
CGMP Deviations
CGMP Deviations.
CGMP Deviations.
CGMP Deviations.
CGMP Deviations.
CGMP Deviations.
CGMP Deviations.
Failed dissolution specifications
CGMP Deviations.
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Lack of Assurance of Sterility
CGMP Deviations.
CGMP Deviations.
CGMP Deviations.
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
CGMP Deviations.
Out of specification due to dissolution.
CGMP Deviations.
CGMP Deviations
CGMP Deviations
Lack of sterility assurance.
Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
CGMP Deviations
CGMP Deviations.
CGMP Deviations.
Lack of process control
Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
Failed Impurities/Degradation Specifications.
Lack of assurance of sterility.
Lack of Assurance of Sterility
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Lack of Assurance of Sterility
Failed Impurities/Degradation Specifications
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Presence of particulate matter.
Lack of Assurance of Sterility
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Lack of Assurance of Sterility
Failed Content Uniformity Specifications
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Failed stability specifications
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Labeling: Label Lacks Warning or Rx Legend
Labeling: Label Lacks Warning or Rx Legend
Incorrect label placed on product: Outer carton label correctly identifies drug product in bottle as ValuHealth Extra Strength Pain Relief Acetaminophen 500 mg,but inner label on bottle says ValuHealth Extra Strength Pain Relief PM
Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
Microbial Contamination of Sterile Products: Out of specifications results were obtained for bacterial endotoxin.
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.